Parkinson's disease is characterized by a gradual loss of dopaminergic neurons, which are 1 associated with altered neuronal activity in the beta band (13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30). Assessing beta band 2 activity typically involves transforming the time-series to get the power of the signal in the 3 frequency-domain. Such transformation assumes that the time-series can be reduced to a 4 combination of steady-state sine-and cosine waves. However, recent studies have suggested 5 that this approach masks relevant biophysical features in the beta band activity-for example, 6 that the beta band exhibits transient bursts of high-amplitude activity. 7
Introduction
Parkinson's disease is a neurodegenerative disease that, most often, initially manifests with 1 motor symptoms such as tremor, rigidity, and bradykinesia. The neurodegenerative process is 2 characterized by a loss of dopamine and death of dopaminergic neurons throughout the basal 3 ganglia-thalamic-cortical system (Rodriguez-Oroz et al., 2009; Kalia and Lang, 2015) . The 4 dopamine loss leads to widespread functional changes in brain activity; for instance, throughout 5 the basal ganglia-thalamic-cortical network, oscillatory activity in the beta band (13-30 Hz) 6 exhibits systematic disease-related changes in Parkinson's disease (Jenkinson and Brown, 7 2011) . The direct influence of dopamine has for example been demonstrated to increase beta 8 band power in the sub-thalamic nucleus (STN) when Parkinson's patients are OFF 9 dopaminergic medication as compared to ON medication (Alonso-Frech et al., 2006; Kühn et 10 al., 2006; Mallet et al., 2008; Giannicola et al., 2010; Neumann et al., 2017) . Increased beta 11 power in the STN and the basal ganglia has further been linked to increased severity of 12 bradykinesia and rigidity in Parkinson's patients (Kühn et al., 2006; Martin et al., 2018) . 13
Disease-related changes in the beta band are found not only in STN and basal ganglia in 14
Parkinson's patients but is also present in the cortex, from where brain activity can be recorded 15 non-invasively while patients are at rest, using magnetoencephalography (MEG) and 16 electroencephalography (EEG) . 17
Studies using MEG to assess neural activity while the participants were at rest show that 18
Parkinson's patients have decreased cortical beta power compared to healthy controls 19 (Bosboom et al., 2006; Heinrichs-Graham et al., 2014) . However, in the early stages of 20 Parkinson's disease, there seems to be an increase in beta power at rest compared to healthy 21 controls (Pollok et al., 2012) . Treatments for Parkinson's disease also seems to be effective 22 through modulation of the cortical beta activity. Administration of dopaminergic medication 23 has been shown to increase the cortical beta power in Parkinson's patients (Heinrichs-Graham 24 et al., 2014; Melgari et al., 2014) , suggesting that dopamine levels and the cortical beta power 25 are inversely connected. Similarly, Parkinson's patients treated with electrical deep brain 26 stimulation (DBS) showed an increase in cortical sensorimotor beta power following DBS 27 compared to off treatment (Airaksinen et al., 2012; Cao et al., 2017) . However, other studies 28 have reported that DBS leads to a broader suppression of 5-25 Hz power in frontal and 29 sensorimotor cortex (Abbasi et al., 2018; Luoma et al., 2018) . 30
Beta bursts in Parkinson's disease 4 It is currently unclear whether the different directions of these disparate findings are due to 31 differences in the Parkinson's patients (e.g., early-stage versus later-stage Parkinson's disease) 32 or if they are due to uncertainties in the methods used to quantify beta activity. Beta activity is 33 traditionally assessed by analyzing the MEG/EEG data in the frequency-domain, using various 34 forms of Fourier-transforms (e.g., wavelet-analysis) of the data. Fourier-based methods assume 35 that the oscillatory activity in the time series can be resolved as a sum of steady-state sine and 36 cosine waves of varying frequency. There is however converging evidence that the oscillatory 37 activity in the beta band does not occur at a steady state, but rather consists of short transient 38 bursts lasting only one to a few beta band cycles (Leventhal et al., 2012; Bartolo and Merchant, 39 2015; Feingold et al., 2015; Sherman et al., 2016) . From the resulting power spectral densities 40 (PSD) it is impossible to tell whether changes in beta band reflect a general change in the 41 amplitude of steady-state oscillations, or if it reflects changes in the occurrence or amplitude of 42 transient beta bursts. In all three cases, the output from the Fourier-transform will sum up to a 43 shift in beta band power. 44
Several recent studies have explored the functional role of transient beta bursts in the motor 45 cortex of healthy subjects. For instance, Shin et al. (2017) showed that the detection rate of a 46 tactile stimulation was higher when the probability of a beta burst immediately before the 47 stimulation was low, suggesting that the beta bursts exhibit a transient inhibitory effect on the 48 processing of incoming sensory signals. The negative relationship between the probability of a 49 beta burst and the detection rate of tactile stimulation has been demonstrated in both mice, 50 monkeys, and humans (Sherman et al., 2016; Shin et al., 2017) . Similarly, Little et al. (2018) 51 showed a negative relationship between the probability of cortical beta bursts before a cued 52 movement and reaction time in a cued reaction task, demonstrating that beta bursts have an 53 inhibitory effect on outgoing movement initiation. Assessment of changes in beta activity in 54 terms of transient bursts-rather than averaging in the frequency-domain-may contribute to a 55 better understanding of what aspect of beta activity that changes in Parkinson's disease due to 56 disease and medication. 57
There is similar evidence on the functional role of transient beta bursts from research assessing 58 beta band activity in midbrain structures. The overall power changes in the beta band in the 59 STN can, for example, be explained as changes in the rate of high beta amplitude epochs 60 (Tinkhauser et al., 2017a (Tinkhauser et al., , 2018 . The high-amplitude beta epochs in STN showed both 61 increased rate and longer durations when the patients were OFF dopaminergic medication as 62 compared to ON medication. Lofredi et al. (2019) used similar measurements from STN in 63 Beta bursts in Parkinson's disease 5 patients undergoing surgery to find a decrease in beta bursts in the period leading up to a 64 movement in a cued reaction task. The relation between beta bursts and movement initiation 65 makes beta burst a potential tool for understanding loss of control and slowing of movement in 66
Parkinson's disease (Tinkhauser et al., 2017b; Lofredi et al., 2019) . 67
Analysis of beta activity at the level of beta bursts appear to be a functionally relevant approach 68 for further understanding sensory-motor processing and may provide new insights into the 69 function of the sensory-motor system that is lost in average based analysis method. Assessment 70 of spontaneous beta bursts in Parkinson's patients from non-invasive recordings, such as MEG 71 might, therefore, provide a more sensitive assessment on how the beta band activity changes 72 due to the disease and may help to resolve the apparently conflicting results that emerge when 73 assuming beta band activity consist of steady-state beta oscillations. 74
In this study, we used non-invasive MEG measurements from Parkinson's patients OFF and 75 ON dopaminergic medication, and measurements from matched healthy controls, to investigate 76 the occurrence of spontaneous transient beta bursts in the sensorimotor cortex. Our primary aim 77 was to compare the characteristics (such as duration, amplitude, rate) of spontaneous beta burst 78 in the sensorimotor cortex of Parkinson's patients to healthy controls. Our secondary aim was 79 to explore whether any of the beta bursts characteristics changed with the presence of 80 dopaminergic medication. Finally, a third aim was to investigate whether any of the beta bursts 81 characteristics were linked to the severity of disease symptoms in Parkinson's disease. 82 2 Materials and methods 2.1 Participants 83 20 patients diagnosed with Parkinson's disease (age 41-85; five female) and 20 healthy controls 84 (age 54-76; eight female) participated in the study. The study was approved by the regional 85 ethics committee (Etikprövningsnämden Stockholm, DNR: 2016/911-31/1) and followed the 86 The patients were instructed to omit their morning dose of dopaminergic medication on the day 110 of participation. Thus, the OFF state was defined as a withdrawal period of 12 hours after the 111 last dopaminergic medication. Patients were further instructed to bring their prescribed dose of 112 medication, which they had to take during the experiment. All patients followed the 113 instructions. 114
Beta bursts in Parkinson's disease 7 Preparation for the MEG recordings began as soon as the participants were briefed about the 115 procedure and signed the written informed consent. The recordings consisted of three minutes 116 where the participants sat with their eyes closed in the MEG scanner. Text on a screen placed 117 in front the participants initially instructed the participants to close their eyes. Participants were 118
instructed not to open their eyes before being told to, and to avoid moving until they were 119 allowed to open their eyes. The recordings began once the experimenter through video 120 observation had assured that participant's eyes were closed. The participants then did two 121 unrelated tasks in the same recording session consisting of an active tapping task (Vinding et 122 al., in prep.) and a task with passive movements (Vinding et al., 2019) . Each MEG recording 123 session took about one hour. 124
When the first session was over, participants had a break outside the scanner. During the break, 125 the participants performed the neurological tests described below, and the patients took 126 medication. The second MEG measurement began approximately one hour after medication. 127
The healthy controls did not take any medication but had a similar duration break and measured 128 twice to accommodate the potential effect of the fixed order of the OFF-ON measurements in 129 patients. 130
Motor function was assessed in all participants using the motor subscale of the Movement 131 giving a representation of the subjects' head shape-was digitalized with a Polhemus Fastrak 144 motion tracker before the measurements. The head shapes were later used to co-register MEG 145 data and structural MRI. Horizontal and vertical electrooculogram (EOG) and 146 electrocardiogram (ECG) were recorded simultaneously with the MEG.
Data processing

148
MEG data were processed off-line by applying temporal signal space separation (tSSS) to 149 suppress artifacts from outside the scanner helmet and correct for head movement during the 150 recordings (Taulu and Simola, 2006) . The tSSS had a buffer length of 10 s and a cut-off 151 correlation coefficient of 0.95. Movement correction was done by shifting the head position to 152 a position based on the median head position during the recording. We then did an independent 153 component analysis (ICA) for each subject using the fastica algorithm (Hyvarinen, 1999) 154 implemented in MNE-Python (Gramfort et al., 2013) in Python 2.7. Components related to 155 saccadic eye-movements and heartbeats were identified based on their correlation with the EOG 156 or ECG and removed from the data. 157
We then applied source reconstruction to the data using noise weighted minimum-norm 158 estimates (dSPM) (Dale et al., 2000) . The noise covariance matrix was estimated from two 159 minutes of empty room data recorded before each session. The source space consisted of 5124 160 evenly spaced points sampled across the white matter surfaces. The surfaces were obtained with 161 the automatic routine for extracting cortical surfaces in Freesurfer (Dale et al., 1999) from 162 individual T1 weighted MRI that were obtained on a GE Discovery 3.0 T or a Siemens Prisma 163 3.0 T MR scanner. One subject did not complete an MR scan, so we used an MRI template 164 (Holmes et al., 1998) warped to the subject's head shape as a substitute. From the MRI, we 165 obtained the inner skull boundary, which was used to create a single compartment volume 166 conductor model to estimate the forward model. 167
The cortical surface was then segmented into anatomical labels based on the automatic labeling 168 algorithm in Freesurfer (Destrieux et al., 2010) . Based on the labels, we extracted data from all 169 point within a region of interest (ROI) consisting of the pre-and post-central gyri and central 170 sulcus of the left hemisphere ( Fig. 1) . We then obtained a combined ROI time course as the 171 first right-singular vector of a singular value decomposition of the source time courses within 172 the ROI, with the sign of the vector normalized relative to the source orientations. 173
The ROI time-series was band-pass filtered between 13-30 Hz using a zero-phase finite impulse 174 response filter to get the beta band time-course. The filter had a transition bandwidth of 3.25 175
Hz for the lower pass-band edge and a transition bandwidth of 7.5 Hz for the upper edge. We 176 then applied a Hilbert transformation to the filtered time-series to obtain the instantaneous beta To asses and compare beta burst, we defined high-amplitude epochs in the envelope of the time-190 series above a fixed threshold defined in order of medians above the median of the envelope 191 for each participant. To determine the value of the threshold, we took the correlation coefficient between the average amplitude of the signal envelope and the number of detected epochs within 193 consecutive 3.0 seconds of data. This gave a single correlation coefficient per threshold per 194 subject, which were averaged across all subjects. The threshold with the highest correlation 195 between the number of epochs and signal amplitude was used as the fixed threshold in the 196 comparisons ( Fig. 1B) . Defining the threshold in orders of medians, rather than an absolute 197 cutoff value, gives a threshold that preserved the statistical properties at the group-level but 198 fitted to the dynamic range of the individual subjects' time-series. Similar methods for defining 199 thresholds have been used to identify beta bursts in event-related studies (Feingold et al., 2015; 200 Shin et al., 2017) . Here we extended the method to resting-state MEG. 201
Once the threshold was defined, we extracted four features of the high-amplitude epochs (Fig. 202 1C). The first feature was the rate of occurrence within the three-minute time-series. The 203 purpose of the first feature was to answer if the beta band were more "bursty" in one group 204 compared to the other and whether it changed due to medication. The second feature was the 205 epoch duration, defined as the time between the epoch reached the half-max of the peak value 206 until it once again reached the half-max of the peak value (unless the half-max of the peak was 207 above the threshold, in which case the time of threshold crossing was used to indicate the onset 208 and offset). The purpose of the second feature was to answer if the high-amplitude epochs 209 resembled "true" bursts (i.e., durations approximating one or two beta cycles) or perhaps 210 showed prolonged high-amplitude activity in one of the groups. The third feature was the inter-211 burst interval, defined as the time from the offset of one epoch to the onset of the next even. 212
The fourth and final feature was the peak amplitude of the envelope within each epoch. 213
Power spectral densities
214
To compare how the time-domain analysis compares to Fourier-based analysis of beta power 215 in the frequency-domain, we calculated the PSD of the unfiltered ROI time-series in the 216 spectrum from 1-48 Hz. We divided the time-series into consecutive epochs of three seconds 217 with a 50% overlap and applied a Hanning taper before applying a fast Fourier transform using 218
FieldTrip (Oostenveld et al., 2011) in MATLAB (R2016b; MathWorks Inc.). 219 First, we tested for differences in age, sex ratio, and MoCA score between the Parkinson's 222 patients and healthy controls to ensure that the demographics of the two groups were adequately 223 matched. Comparison of age and MoCA score by "Bayesian t-tests" (Rouder et al., 2009) using the BayesFactor package (Morey and Rouder, 2018) for R (R Core Team, 2013) . The test gives 225 the ratio of evidence for the hypothesis that there is a group difference versus the null-226 hypothesis of no difference between groups. To test for difference in the male-female ratio 227 between groups, we used a Bayesian test for unequal multinomial distributions (Gûnel and 228 Dickey, 1974) . 229
Statistics
Power spectral densities 230
The PSDs were compared with pairwise cluster-based permutations tests across the spectrum 231 from all 1-48 Hz. Independent t-test was first done on all frequency bins in the PSD. Adjacent 232 t-values (df = 18 for within-group and df = 36 for between-group comparison) above or below 233 the critical value (alpha < 0.05, two-tailed) were summed to gain the cluster T-value and then 234 repeated on permutated datasets with randomized labels (n = 1000). The null hypothesis was 235 rejected if the observed dataset had a largest cluster T-value above the 95th percentile of the 236 permuted T-values (Maris and Oostenveld, 2007) . The PSDs were compared across sessions 237 within groups, between groups within sessions, and the interaction between groups and 238 sessions. In addition to comparing the full spectrum between groups and sessions, we compared 239 the relative power in the beta band by integrating the PSD in the beta range (13-30 Hz) and 240 dividing it by integral of the full spectrum. The comparison of the relative beta power was done 241 by pairwise Bayesian t-tests with the BayesFactor package in R. 242
Beta burst features 243
The rate, duration, inter-burst interval, and peak amplitude were all analyzed by Bayesian 244 mixed-effect regression, estimated in R with the brms package (Bürkner, 2017) . The models 245 used uninformative priors and were estimated by Markov-Chain Monte-Carlo sampling 246 drawing 20.000 samples across four chains and discarding the first half of each chain. The 247 convergence of the chains was confirmed by checking R ≈ 1 (Gelman and Rubin, 1992) . distributed. The models for duration and peak amplitude used shifted log-normal link functions 255 that take the values subtracted a constant to follow a log-normal distribution.
Comparison between groups and sessions was done by comparing the marginal evidence-or 257
Bayes factor (BF)-between models with and with the factor Group, Session, and the 258 interaction between Group and Session as fixed effects. BF > 1 is evidence for the alternative 259 hypothesis, whereas BF < 1 is evidence for the null-hypothesis. We use the guidelines by 260 Wetzels et al., (2011) to determine the strength of the evidence where 0.33 < BF < 3 is taken as 261 conclusive support for the alternative-or null-hypnosis. Values between 0.33 and 3 are 262 inconclusive evidence. Post hoc hypothesis testing was done testing if at least 95% posterior 263 distribution of individual parameters did not contain zero. The resulting test statistic is the 264 probability P ranging from 0 to 1. P close to 0 is evidence for a difference between conditions, 265
whereas P close to 1 provides evidence against a difference. We used the 95% posterior 266 distribution corresponding to critical alpha = 0.05. 267
Comparison across thresholds 268
To explore if the inference from the primary analysis was dependent on the threshold used to 269 define the high-amplitude epochs, we repeated the comparison of the high-amplitude epoch rate 270
between groups and sessions across thresholds. At each threshold-starting at the median to 271 five times the order of median in steps of 0.1-we defined epochs as described above. The 272 number of beta bursts at each threshold was analyzed by mixed-effect Poisson regression as in 273 the primary analysis. We then compared models with and without the factor Group, Session, 274 and the interaction between Group and Session to get a Bayes factor for each factor at each 275 threshold. The model used uninformative priors and was estimated by Markov-Chain Monte-276 Carlo sampling drawing 4.000 samples across four chains and discarding the first half of each 277 chain. 278
Beta burst rate and motor symptoms 279
In addition to the group-level comparisons, we investigated the relationship between the burst 280 rate and motor symptom severity measured with the MDS-UPDRS-III for the Parkinson's 281 patients. Since previous studies have shown that (frequency-domain) beta power is correlated 282 with specific motor symptoms of rigidity and bradykinesia (Airaksinen et al., 2012 (Airaksinen et al., , 2015 283 Melgari et al., 2014) , we divided the MDS-UPDRS-III scores into six subscales of different 284 motor symptoms according to the factors described by Goetz et al., (2008) with the exception 285 that left-and right-side bradykinesia was combined into one factor. Each MDS-UPDRS-III 286 factor (midline function, rest tremor, rigidity, bradykinesia, postural and kinetic tremor, lower 287 limb bradykinesia) was modeled by mixed-effect Poisson regression as a linear function of the 288 burst rate and subject and session as random intercepts. With these models, we tested the 289 Beta bursts in Parkinson's disease 13 association between beta burst rate and the MDS-UPDRS-III factor scores by testing if at least 290 95% of the posterior distribution did not contain zero. All models model used uninformative 291 priors and was estimated with brms (Bürkner, 2017) by Markov-Chain Monte-Carlo sampling 292 drawing 20.000 samples across four chains and discarding the first half of each chain. 293
Results
Group characteristics
294
The groups are adequately matched for comparison as there were no systematic differences in 295 the demographic variables: male/female ratio (BF = 0.60), age (BF = 0.41), and cognitive ability 296 (BF = 0.39), see Table 1 . 297
The Parkinson's patients showed 26%-72% (mean 49%) improvement on motor symptoms on 298 the MDS-UPDRS-III in the ON state compared to the OFF state (BF = 4.70*10 7 ). 299
Power spectral densities
300
The cluster-based permutations test of the PSDs (Fig. 2 ) did not show any clusters of difference 301 in any of the comparisons; thus, we cannot reject the null hypothesis that there is no difference 302 between groups or sessions. 303 
307
Comparison of the relative beta power gave evidence against a different between the first and 308 second session for the controls (BF = 0.37) or between ON and OFF medication for the Parkinson's patients (BF = 0.34). The comparison between the groups in the first session/OFF 310 medication showed evidence for a difference between the groups but only as inconclusive 311 evidence (BF = 1.27) and gave inconclusive evidence against a difference between the groups 312 in the second session (BF = 0.87). Based on the comparisons in the frequency domain, we are 313 not able to conclude that there is a difference between groups or between sessions. 314
Beta burst rate
315
The Parkinson's patients showed an average rate of 106 bursts/min (SD: 8) in the first 316 session/OFF medication and 108 bursts/min (SD: 11) in the second session/ON medication. 317
The controls had an average rate of 120 bursts/min (SD: 11) in the first session and 116 318 bursts/min (SD: 15) in the second session. Fig. 3 shows the burst rate for all subjects across 319 groups and sessions. 320 
323
The model comparison showed evidence for an effect of Group (BF = 10.9) but gave evidence 324 against an effect of Session (BF = 0.062) and gave evidence against interaction between Group 325 and Session (BF = 0.24). 326
The Parkinson's patients had 5-17% (median: 11%) lower rate in the OFF state compared to 327 healthy controls (P < 0.0016). The change in rate from the OFF to the ON state varied from a 328 4% reduction to 8% increase (median 2% increase) and was not significantly different from 329 zero (P = 0.60). The healthy controls showed a change in burst rate from the first to the second 330 that ranged from a 9% decrease to a 2% increase (median: 3% decrease). The change in burst rate between session for the healthy controls was not significantly different from zero (P = 332 0.22). 333
Burst duration
334
The high-amplitude epochs showed that the beta bursts were short, with a median duration 335 between 73-76 ms in both sessions and groups (see Table 2 ). 95% of the epoch duration 336
distributions fell within 35-170 ms. The median duration of the beta bursts corresponded 337 roughly to a single oscillatory cycle in the beta frequency range (approximately 13-14 Hz). 338
The comparison of the burst durations showed evidence against an effect of Session (BF = 339 0.046), gave evidence against an effect of Group (BF = 0.17), and gave evidence against the 340 interaction between Session and Group, though the evidence is in the inconclusive range (BF = 341 0.59). 342 dSPM: dynamic statistical parametric map 344
Inter-burst intervals
345
The inter-burst intervals had a skewed distribution with a high probability of short intervals 346 below 200 ms with few longer intervals that could last up to seconds (Fig. 4B) . The model 347 comparison showed evidence against an effect of Session (BF = 0.049) and evidence for an 348 effect of Group (BF = 283). For the inter-burst intervals, there was evidence for an interaction 349 between Group and Session (BF = 5173). The model showed a median inter-burst interval of 187 ms (mean: 631 ms, 95%-I: 9-3903 ms) 355 for patients OFF medication, compared to a median inter-burst interval of 136 ms (mean: 442 356 ms, 95%-I: 7-2887 ms) for healthy controls in the first session (P < 10 -4 ). The median inter-357 burst interval decreased to 177 ms (mean: 560 ms, 95%-I: 9-3686 ms) in the ON medicated, 358 corresponding to a 10% decrease (CI: 4%-14%) in the inter-burst intervals from the OFF to ON 359 medication state (P = 2*10 -4 ). The inter-burst interval changed in the opposite for the healthy 360 controls and increased by 8% (CI: 3-14%) between sessions (P = 0.003). 361 3.6 Peak amplitude 362 Fig. 4A depicts averaged beta burst time-locked to the peak amplitude. The peak amplitude of 363 the beta bursts only differed between sessions independent of the group. The model comparison 364 of the peak amplitude showed evidence for an effect of Session (BF = 1.6*10 9 ), but evidence 365 against an effect of Group (BF = 0.46) and evidence against the model that included the 366 interaction between Session and Group (BF = 0.48)-though the BFs are in the inconclusive 367 range for the two latter model comparisons. The peak amplitude increased for both controls and 368 patients in the second session with an increase of 4% (CI: 3-5%; P < 10 -4 ) for controls and an 369 increase of 2% (CI: 1-3%; P = 0.002) for the Parkinson's patients. 370
Comparison across thresholds
371
To investigate how the threshold for defining beta bursts influenced the inference, we repeated 372 the comparison of the burst rate across a range of thresholds. Fig. 5B shown the Bayes factors 373 of the comparison across the thresholds. The model comparisons for all thresholds above one 374 unit of medians favored a difference in the number of beta bursts between controls and patients 375 with the patients having fewer beta bursts than the controls. At higher thresholds, the 376 comparison favored and interaction between Group and Session, with an increase in the burst 377 rate from OFF to ON but also increased variation (Fig. 5A) . Since the inference one would draw 378 at different thresholds is consistent across thresholds (with the exception of the very low and 379 high thresholds), we conclude that the inference is not too dependent on the precise numerical 380 threshold. UPDRS-III from the regression models. The burst rate scaled negatively with bradykinesia (P 390 = 0.038). The regression model predicted a decrease of 29% (95%CI: 10-45%) in bradykinesia 391 rating when the burst rate increased by 10. The burst rate further scaled negatively with 392 postural/kinetic tremor (P = 0.028), predicting 40% (95%CI: 16-59%) decrease in symptom 393 rating when the burst rate increased by 10. We saw no evidence that midline function (P = 0.44), 394 rest tremor (P = 0.71), rigidity (P = 0.87), nor lower limb bradykinesia (P = 0.28) scaled with 395 the burst rate. 
Discussion
The primary aim of this study was to explore whether beta burst characteristics differed between 402
Parkinson's patients and healthy controls. As a secondary aim, we also explored whether beta 403 burst characteristics vary within Parkinson's patients because of dopaminergic medication; and 404 finally, as a third aim, explored whether beta burst characteristics were related to symptom 405 severity in Parkinson's disease. 406
When the Parkinson's patients were OFF medication showed a 6-17% lower beta burst rate 407 compared to healthy controls. This reduction of in beta burst rate was still present when the 408 patients were ON medication. Neither the duration nor the amplitude of the beta bursts differed 409 between patients and controls. Our results add to the evidence that the cortical activity in the 410 beta band exhibits transient bursts lasting a one or two cycles. This is in line with the research 411 from Sherman et al. (2016) , who proposed that beta burst in the cortex is caused by a short 412 distal drive in the upper laminar layers lasting around 50 ms in combination with a sustained 413 excitatory proximal drive between the upper and lower cortical layers. The consistency in 414 duration and amplitude suggests that some components of the mechanisms that generate the 415 cortical beta bursts are preserved in Parkinson's disease, while the rate of bursts decreases with 416 the disease and with symptom severity. This reduction in spontaneous beta bursts in the 417 Beta bursts in Parkinson's disease 20 sensorimotor cortex could potentially be driven by a reduction in distal connections from 418 thalamus or the basal ganglia. 419
The distribution of the inter-bursts interval more resembled the distributions of the healthy 420 controls when patients were on medication. What this means in terms of disease-related 421 mechanisms is currently unclear as the underlying dynamics that drive the beta bursts is 422 unknown. It is possible that the shift in inter-burst interval following dopaminergic medication 423 is driven by a change in the distal drive from dopamine modulated activity in basal ganglia or 424 thalamus. However, more research is needed to understand how the cortical beta bursts are 425 driven by deeper sources, which directions the connection goes, and how this is modulated by 426 dopaminergic medication. The effect of dopaminergic medication on the beta band seems to be 427 much more complex than changes in the average power in the beta band. Rather, by assessing 428 the beta activity in terms of beta burst and analyzing the characteristics of these events, it seems 429 that what mainly changes in the temporal distribution of transient beta bursts. 430
We did not find an effect of dopaminergic medication on the burst rate, nor on the burst 431 duration. Since the study was exploratory and we did not have prior estimates of an expected 432 effect size of medication and that our sample size was relatively small (n = 19), there might be 433 effects of medication that we have not detected with this analysis approach. At higher thresholds 434 than the one used in the main analysis ( Fig. 5) , there was evidence for an effect of medication 435 on the burst rate. 436
In the Parkinson's patients, the decrease in beta burst rate was associated with an increase in 437 symptom severity for bradykinesia and postural/kinetic tremor. Such a link between burst rate 438 and bradykinesia is in line with previous studies showing that decreased beta power in the 439 cortex is related to increased bradykinesia (Airaksinen et al., 2012 (Airaksinen et al., , 2015 Melgari et al., 2014) . 440 A reduction in the average PSD is compatible with the reduction in the number of spontaneous 441 high-amplitude bursts as well as a reduction in sustained oscillatory activity. However, in our 442 results, we did not observe any conclusive differences between Parkinson's patients and healthy 443 controls in the averaged PSD that corresponds to those we report for the analysis of beta bursts 444 (only an inconclusive trend for the relative beta power). For our data, frequency-domain 445 analysis using the traditional Fourier-transform method thus seems to be less sensitive in 446 picking up statistically meaningful differences in beta activity between Parkinson's patients and 447
healthy controls compared to an analysis based on individual burst events.
The variation between the sessions for the healthy controls may reflect the test-retest variability 449 of the measurements, which were between a 9% decrease to a 2% increase in beta burst rate. 450
This variation can also reflect a circadian effect on the spontaneous beta bursts. It has previously 451 been shown that the frequency domain beta power varies with the time of the day (Wilson et 452 al., 2014) . It is plausible that similar circadian effects apply to beta bursts in the time-domain. 453
All participants-Parkinson's patients and controls alike-were tested in the morning and again 454 before noon on the same day in our study. 455
The presence of cortical beta band activity is inversely related to motor function: a decrease in 456 beta band activity indicates an increased sensitivity to efferent and afferent sensorimotor 457 signals, whereas increased activity has been linked to inhibition of sensorimotor signals 458 (Brown, 2007; Engel and Fries, 2010) . Close temporal proximity between beta bursts and go 459 cues leads to longer reaction times (Little et al., 2018; Lofredi et al., 2019) and less likelihood 460 of detecting sensory stimuli close to the sensory threshold (Shin et al., 2017) , suggesting that 461 the proximity of beta bursts blocks immediate sensorimotor processing. Spontaneous beta 462 bursts thus seems to have a transient inhibitory effect on the sensorimotor processing, but might 463 at the same time serve as a signal that is necessary to maintaining a continuous optimal state of 464 sensorimotor processing (Engel and Fries, 2010; Jenkinson and Brown, 2011) . This 465 interpretation entails that the beta bursts serve as an immediate updating of the sensorimotor 466 system by integrating the previous motor signal and proprioceptive signal (Leventhal et al., 467 2012) . The beta bursts might be inhibitive, as evidenced by their behavioral effects on event-468 related sensorimotor tasks (Shin et al., 2017; Little et al., 2018) , but keeping maintenance of 469 the sensorimotor system over a longer time. The inverse relation between the number of 470 spontaneous beta bursts and bradykinesia, that we report in this study, might hence be due to a 471 deficit in the updating of the sensorimotor system, which leads to suboptimal utilization of 472 neural resources when initiating and performing movements manifesting as bradykinesia and 473 kinetic tremors. 474
It is well known that beta activity is altered in Parkinson's disease, which is often evident at the 475 frequency domain on decomposed and averaged time-series of electrophysiological activity. 476
However, that approach implicitly assumes that the average signal is representative of the whole 477 time-series. The neuronal oscillations in the beta band change over time by exhibiting transient 478 beta bursts lasting 70-80 ms. We have shown that the burst duration is similar for both healthy 479 adults and Parkinson's patients-but that the burst rate is reduced in Parkinson's disease. The 480 spontaneous dynamics in the beta band, such as burst events and burst characteristics, might hold further information that is relevant for understanding Parkinson's disease and the 482 development of motor symptoms. Modulation of the dynamic changes in the beta activity due 483 to the dopaminergic medication has been shown in deep-brain recordings from STN in 484
Parkinson's patients (Tinkhauser et al., 2017a, b) . Recordings of the electrical field in STN is 485 only done in patients who undergo brain surgery. It is, therefore, not feasible for diagnostic 486 purposes. Here we show that Parkinson's patients exhibit a reduction in the beta bursts rate 487 compared to healthy controls and that this can be measured from the cortex non-invasively 488 using MEG. 2 A) We recorded three minutes of resting-state MEG. Raw MEG data were first processed with 3 tSSS and ICA to remove artifacts. We then did a dSPM source reconstruction and extracted 4 the time-series from an ROI consisting of the pre-/postcentral gyri and central sulcus. The 5 ROI time-series was filtered to the beta range (13-30 Hz) and Hilbert-transformed. B) High-6 amplitude epochs were determined based on a threshold defined as the cutoff that had the 7 highest correlation between the number of epochs and amplitude in consecutive 3.0 s 8 segments. The vertical line indicates the threshold used in the analysis. C) Once the threshold 9 was defined, we compared four features of the high-amplitude epochs: rate (i.e., count 10 occurrence high-amplitude epochs), duration (blue arrow), the inter-burst interval (red 11 arrow), and peak amplitude (black arrow). MEG: magnetoencephalography; ICA: independent 12 component analysis; dSPM: dynamic statistical parametric mapping; ROI: region of interest. 13 
Figure legends
